Overview

Dalbavancin Outpatient Pilot

Status:
Not yet recruiting

Trial end date:
2023-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this research is to determine if a new antibiotic called dalbavancin will work to treat and cure certain infections while reducing the need for daily antibiotics by vein.

Phase:

Phase 4

Details

Lead Sponsor:

Wake Forest University Health Sciences

Treatments:

Anti-Infective Agents
Dalbavancin
Teicoplanin